Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read ...
With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...
How-To Geek on MSN
The 3 best logical functions I always use in Excel
Make Excel evaluate your data for you.
Real-world and clinical trial data underscore long-term safety and effectiveness in pediatric and adult NPC patients ...
The Register on MSN
How the GNU C compiler became the Clippy of cryptography
Security devs forced to hide Boolean logic from overeager optimizer FOSDEM 2026 The creators of security software have encountered an unlikely foe in their attempts to protect us: modern compilers.… ...
A small portable device featuring timer, clock, and calendar functions, equipped with a simple and functional interface and a truly long battery life.
Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...
Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading institutions across the ...
The partial government shutdown is a lot different from the record-long shutdown in the fall. That’s mostly because the ...
WISN 12 News on MSN
Here's what could be affected if the government shuts down again
The federal government is on the verge of partially shutting down, with Senate Republicans and Democrats at an impasse over ...
An incentive gap is undermining responsible disclosure. For CISOs, this is gradually evolving into a risk management nightmare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results